Czechia· CZ-0234436
CAPECITABINE MYLAN
A capecitabine product containing capecitabine, registered in Czechia by Mylan Ireland Limited, Dublin. The same ATC class is registered in 17 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Capecitabine is registered in 17 of 19 countries.
Countries holding a registration under ATC L01BC06 (capecitabine), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 10 of them publish a price we can compare per daily dose
Capecitabine · ATC L01BC06
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of capecitabine costs, country by country.
Normalised to the WHO defined daily dose (3 g), the median price runs from $2.73 in United States to $15.27 in Switzerland — a ×5.6 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Capecitabine · price per daily dose (3 g)
USD · FX 28 Sept 2026
- CH Switzerland$15.27
- IT Italy$12.14
- FR France$8.39
- US United States$2.73 (acquisition cost)
The record
At a glance
SÚKL (Czech Republic)- Active substance
- CAPECITABINE
- Manufacturer
- Mylan Ireland Limited, Dublin
- Country
- Czechia (CZ)
- ATC code
- L01BC06
- ATC class
- Capecitabine
- Defined daily dose
- 3 g, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
366 interactions on record for capecitabine.
Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Capecitabine · interactions on record
366 records
- 35 severe
- 103 moderate
- 27 minor
- 200 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- Folic acidB03BB01severe
- CladribineL01BB04severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Capecitabine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatescapecitabineCamber Pharmaceuticals, Inc.
- SpainCAPECITABINA ACCORD 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- FinlandCapecitabin ActavisActavis Group PTC ehf
- BelgiumCapecitabin Sandoz 150 mgSandoz
- NetherlandsCapecitabine Accord 150 mgAccord Healthcare S.L.U.
- SwedenCapecitabin STADA 150 mg Filmdragerad tablettSTADA Arzneimittel AG
- FranceCAPECITABINE ACCORD 150 mg, comprimé pelliculéACCORD HEALTHCARE (ESPAGNE)
- PolandCapecitabine AccordAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Capecel, Capecitabin Sandoz
- Bulgaria · Капецитабин Алуфарма, Капецитабин Зентива К.С
- Cyprus · Capecitabine Koanaa 150mg, Capecitabine Koanaa 500mg
- Germany · Capecitabin Al, Capecitabin Amarox
- Denmark · Capecitabin Stada, Capecitabin Zentiva
- Estonia · Capecitabine Zentiva, Capecitabine Zentiva K.S.
- Spain · Capecitabina Glenmark, Capecitabina Kern Pharma
- Finland · Capecitabine Orion
- France · Capecitabine Arrow, Capecitabine Biogaran
- United Kingdom (Northern Ireland) · Capecitabine Amarox, Capecitabine Dr. Reddy's
- Greece · Capecitabine Mylan, Capibine
- Croatia · Kapecitabin Jgl 500 Mg, Kapecitabin Sandoz
- Hungary · Capecitabin Onkogen, Capecitabine Pharmacenter
- Iceland · Capecitabine Accord, Capecitabine Medac
- Italy · Capecitabina Mylan, Capecitabina Zentiva
- Liechtenstein · Capecitabine Accord, Capecitabine Medac
- Lithuania · Capecitabine Zentiva, Capecitabine Zentiva K.S.
- Latvia · Capecitabine Zentiva, Capecitabine Zentiva K.S.
- Malta · Capecitabine Pharmacare, Kapetral
- Netherlands · Capecitabine Amarox, Capecitabine Cf
- Norway · Capecitabine Accord, Capecitabine Medac
- Poland · Capecitabine Glenmark
- Portugal · Capecitabina Aurovitas, Capecitabina Farmoz
- Romania · Capecitabină Dr. Reddy's, Cerex
- Sweden · Capecitabin Stada, Capecitabine Orion
- Slovenia · Kapecitabin Fresenius Kabi
- Slovakia · Capecitabine Pharmacenter, Capecitabine Pharmagen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b4bf9fe4-058e-468a-9727-4fea92669dc1 GET /v1/drugs/b4bf9fe4-058e-468a-9727-4fea92669dc1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "150MG",
"pack_size": "60X1 II",
"substance": "CAPECITABINE",
"cz_kod_sukl": "0234436",
"product_type": "CH",
"substance_codes": "14083",
"registration_state": "B",
"registration_number": "44/406/15-C"
}See everything about capecitabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.